Contract facts
UnrestrictedNo full NAICS 811210 intel page yet. Browse NAICS intelligence
Complete Service Agreement for Two (2) Operetta CLS High-Content Imaging Systems, Six (6) Opera Phenix Confocal Micros… is a federal Unrestricted award for National Institutes Of Health Olao held by Revvity Health Sciences, Inc. Estimated value $770K ($770K obligated). Current period of performance ends Sep 23, 2027. Last award drew 1 bidder. Place of performance: HOPKINTON MA. Related solicitation NOI-NIAID-26-01542.
Complete service agreement for two (2) operetta cls high-content imaging systems, six (6) opera phenix confocal microscopy systems, and associated integrated equipment
Recompete timing
PublicCurrent PoP ends Sep 23, 2027 (341 days remaining). Agencies typically plan 12–18 months ahead — at 11.2 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75N98026P00405? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordRevvity Health Sciences, Inc — $19.9M obligated across 263 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N98026P00405?
75N98026P00405 (Complete service agreement for two (2)) is a National Institutes Of Health Olao award with a potential value of $770K, currently held by Revvity Health Sciences, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N98026P00405?
National Institutes Of Health Olao awarded 75N98026P00405 to Revvity Health Sciences, Inc (potential $770K).
Who is the incumbent on 75N98026P00405?
Revvity Health Sciences, Inc is the incumbent with $19.9M across 263 related awards in SCOUT’s public footprint. The current period of performance ends Sep 23, 2027.
When does Revvity Health Sciences, Inc’s 75N98026P00405 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 23, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75N98026P00405? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.